Ethyl Biscoumacetate
Overview
Ethyl biscoumacetate is an orally administered coumarin anticoagulant with actions similar to those of warfarin . It has been used in the management of thromboembolic disorders.
Categories
- 10 Drugs affecting the blood
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Hyaluronidase's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 300 mg | 300 (300) | As recommended. | Oral | |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Hyaluronidase is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Hyaluronidase is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Hyaluronidase
Back to top
Manufacturers of
Ethyl Biscoumacetate
in Pakistan
Back to top
Previous Drug Generic - Next Drug Generic